The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Robert F Kennedy Jr has issued a 90-day pause for a $200million Biden-era contract with Vaxart Inc to develop a new oral ...

Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a vaccine maker.

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a ...

The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr comes as the U.S. records its first ...

An upbeat tone is seeping into markets as investors dig into Nvidia's quarterly earnings beat, which signaled plenty of scope ...

Novavax's net loss was $81 million for the quarter ended December 31, compared with a net loss of $178.3 million a year ago.